Cancer Treatment

October 26, 2026
What Clinical Trials Really Show About Tigilanol Tiglate from the Blushwood Berry
A viral social media post revived interest in the rainforest drug, but current human trials reveal targeted local results rather than a…
October 18, 2026
European Regulators Back Breakthrough Pancreatic Cancer Drug Rasonque
The EMA has recommended approval for daraxonrasib, a daily pill that doubles survival rates for patients with metastatic pancreatic adenocarcinoma.
October 15, 2026
FDA expands Anktiva approval to cover papillary-only bladder cancer, first treatment for this group
The FDA has broadened Anktiva’s use with BCG to include patients with BCG-unresponsive, high-grade papillary-only non-muscle-invasive bladder cancer, offering a bladder-preserving option…
October 1, 2026
Breakthrough that helped Jimmy Carter may aid future patients, experts say
Rome, October 1 — The mechanics here are straightforward: immunotherapy, a breakthrough in cancer treatment, has generated significant revenue for biotechnology companies,…
July 17, 2026
How Oncotype DX Works: The 21-Gene Recurrence Score Explained
MUNICH, July 17 — A gene expression profiling test that has become a standard tool in breast cancer treatment decisions works by…
July 17, 2026
Real-World Oncotype DX Adoption: Rates and Key Challenges
REDWOOD CITY, July 17 — On a quiet stretch of industrial park off the 101, a medical revolution that began with a…
July 17, 2026
Oncotype DX Test Cuts Chemo Use and Costs in Breast Cancer
MADISON, Wisconsin, July 17 — The genomic test Oncotype DX has fundamentally altered the strategic calculus of breast cancer treatment, shifting the…
July 17, 2026
Trethera Scientist Dr. Gary J. Peltz Leads dCK Inhibitor Development
LOS ANGELES, July 17 — On the seventh floor of a biotechnology office building here, Dr. Gary J. Peltz is closing in…
July 15, 2026
Timely treatment key in under-50 bowel cancer cases
INDIANAPOLIS, July 15 — A study published yesterday by researchers at the Indiana University School of Medicine is bringing new urgency to…
July 15, 2026
Bowel Cancer Delay Over 45 Days Raises Metastasis Risk 55%
INDIANAPOLIS, July 15 — The shift in bowel cancer treatment is no longer just about detecting it early. A new study from…
July 15, 2026
NHS cancer target missed: 70% treated in two months
LONDON, July 15 — The shift is subtle but significant: the two-month window the NHS gives itself to start cancer treatment may…
July 15, 2026
Delays in chemo before surgery risky for bowel cancer patients
INDIANAPOLIS, July 15 — A new study from the Indiana University School of Medicine has shed light on a critical window of…
July 14, 2026
FDA Warns 45 Percent of CAR-T Trial Patients Had Cytokine Storm
WASHINGTON, July 14 — A June 2024 clinical trial for the investigational CAR-T therapy CTX-112 recorded cytokine release syndrome in 45 percent…
July 14, 2026
Immunotherapy harnesses immune system to fight cancer tumors
NEW YORK, July 14 — When James Allison and Tasuku Honjo shared the Nobel Prize in Physiology or Medicine in 2018, they…
July 13, 2026
McGill University leads as hub for cancer clinical trials
MONTREAL, July 13 — McGill University has announced a new partnership with HDT Bio, a biotechnology firm, to advance clinical trials for…
July 10, 2026
From Jenner’s smallpox vaccine to modern immunotherapy
MANILA, July 10 — The story of how humanity learned to fight disease is a long one, and for families across Asia,…
July 10, 2026
Immunotherapy Side Effects Impact Up to 60% of Cancer Patients
WASHINGTON, July 10 — The strategic calculus of cancer treatment is shifting, and with it comes a new set of battlefield risks…
July 10, 2026
FDA Approves Eight New Immunotherapies in 2022 Alone
WASHINGTON, July 10 — The first checkpoint inhibitor landed in March 2011, a drug called ipilimumab, approved for melanoma. Since then, the…
July 7, 2026
New CAR-T Therapy Shows 83% Remission in Aggressive Blood Cancers
MANILA, July 7 — For families across the region watching loved ones battle blood cancers that keep returning, a new treatment option…
July 7, 2026
Owerko Centre Expands Clinical Trials with $35M Investment
CALGARY, July 7 — A major investment announced yesterday is set to transform how quickly families across Alberta, and potentially beyond, can…
July 3, 2026
Researchers Use Vitamin B12 to Bypass Blood-Brain Barrier in Glioblastoma Fight
Glioblastoma kills. It kills fast. Most patients get fifteen months, if they’re lucky. Surgery, radiation, chemotherapy — the standard toolkit — rarely…
July 3, 2026
Researchers Use Vitamin B12 to Deliver Glioblastoma Drug Past Blood-Brain Barrier
History is littered with promising cancer treatments that worked beautifully in mice and then fell apart in people. That sobering fact hangs…
July 2, 2026
Surgeons Outline Three-Step Treatment Sequence for Early Breast Cancer
MANILA — Three words define breast cancer treatment when caught early: surgery, radiation, drugs. The sequence matters. The numbers matter. Two types…
June 30, 2026
Young cancer survivor Kayla Esson shares remission news after months of treatment
Kayla Esson was in a hospital room when the words hit her. Her consultant, Dr. Gavin Preston, told her the cancer was…